Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Metal ions are positively charged atoms formed when metals lose electrons. They play essential roles in diverse biological processes, acting as structural components, enzyme cofactors, signaling molecules, and electron transfer mediators. Their involvement spans from maintaining cellular function to influencing disease development. Therapeutic strategies targeting metal ions include chelation to manage toxicity and metal-based drugs for various diseases.
Varies depending on the specific metal ion and its interaction with biological molecules. Chelating agents bind metal ions, altering their bioavailability and function. Metal-based drugs exert therapeutic effects through various mechanisms, including DNA damage (cisplatin) or immunomodulation (auranofin).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Metal Ions (General).